Accordingly, PCSK9 LOF or pharmacological inhibition during sepsis may lead to the significant reduction in these dysfunctional lipids with consequent beneficial effects on endothelial dysfunction [35]. The gene discussed is PCSK9; the disease is endothelial dysfunction.